Iron infusion in pregnancy and dental dysplasia in children—is there a link?
Some intravenous iron preparations cause hypophosphatemia mediated by increased fibroblast growth factor 23. This hypophosphatemia lasts for weeks or months and, when administered to pregnant women, could affect fetal tooth mineralization, which starts in the fourth month of pregnancy. The fetus req...
Saved in:
| Main Authors: | Gabriela Amstad, Tilo Burkhardt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pediatrics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2025.1583241/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transient Hypophosphatemia as Possible Adverse Outcome after Iron Deficiency Anemia Treatment with Ferric Carboxymaltose – Single Center Experience
by: Nikolina Brkić, et al.
Published: (2024-01-01) -
Comparative Impact of Intravenous Iron Sucrose and Ferric Carboxymaltose on Hypophosphatemia and Anemia Parameters in Iron Deficiency Anemia: A Retrospective Study
by: Aslan S, et al.
Published: (2025-06-01) -
Assessing efficacy and safety of iron (III) hydroxide oligoisomaltosate in reproductive-age women with iron deficiency anemia
by: M. D. Andreeva, et al.
Published: (2023-03-01) -
The U-shaped association between initial serum phosphate level and mortality of traumatic brain injury patients
by: Ruoran Wang, et al.
Published: (2025-06-01) -
The Effect of Ferric Carboxymaltose on Fibroblast Growth Factor 23 (FGF23) in Children with Iron Deficiency Anemia Due to Gastrointestinal Diseases
by: Maria Ntoumpara, et al.
Published: (2024-11-01)